http://hdl.handle.net/10608/11725 2026-05-06T00:44:28Z 2026-05-06T00:44:28Z Jordan, Bertrand http://hdl.handle.net/10608/11967 2022-10-18T00:03:07Z 2021-01-01T00:00:00Z

Chroniques génomiques - L’héritage d’Henrietta Lacks Jordan, Bertrand Many developments in biology and biotechnology have relied on the HeLa cell line, originally derived in 1951 from a Black cancer patient without her knowledge. This origin became generally known at the turn of the century, and the patient’s descendants have sought and obtained some recognition and some control but little compensation. They have now retained two famous attorneys to sue a biotech firm for very extensive damages, with more legal action planned against other companies. This may have important repercussions for the biotech industry, and raises complex issues regarding ownership of biological material and compensation to patients from whom these materials have been obtained.

2021-01-01T00:00:00Z Lemarié, Jérémie Santos-Zas, Icia Ait-Oufella, Hafid http://hdl.handle.net/10608/11964 2022-10-18T00:03:31Z 2021-01-01T00:00:00Z

Les lymphocytes T CD8 + cytotoxiques aggravent le remodelage cardiaque délétère post-ischémique Lemarié, Jérémie; Santos-Zas, Icia; Ait-Oufella, Hafid

2021-01-01T00:00:00Z Majlessi, Laleh Charneau, Pierre http://hdl.handle.net/10608/11961 2022-10-18T00:03:38Z 2021-01-01T00:00:00Z

Un candidat vaccin lentiviral anti-Covid-19 administrable par voie intranasale Majlessi, Laleh; Charneau, Pierre

2021-01-01T00:00:00Z Moulay, Gilles Bitoun, Marc Furling, Denis Vassilopoulos, Stéphane http://hdl.handle.net/10608/11966 2022-10-18T00:03:46Z 2021-01-01T00:00:00Z

Comment l’épissage alternatif contribue au contrôle de la plasticité des structures de clathrine Moulay, Gilles; Bitoun, Marc; Furling, Denis; Vassilopoulos, Stéphane

2021-01-01T00:00:00Z